Company Biophytis S.A.

Equities

ALBPS

FR0012816825

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Quarterly earnings - Rate of surprise

Sector Bio Therapeutic Drugs

Market Closed - Euronext Paris Other stock markets 16:35:06 02/05/2024 BST			5-day change	1st Jan Change
0.84 ^EUR	0.00%		+33,500.00%	+16,370.59%

04-25	European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	MT
04-25	Top Premarket Decliners	MT

Biophytis S.A. is a biotechnology company in the clinical stage specialized in the development of drug candidates to slow degenerative processes and improve functional capacity in patients with age-related diseases, including respiratory failure in patients suffering from COVID-19.

The company is located in Paris, France and Cambridge, Massachusetts.

Number of employees: 22

Managers	Title	Age	Since
Stanislas Veillet CEO	Chief Executive Officer	58	14/09/06
Nicolas Fellmann DFI	Director of Finance/CFO	55	21/05/23
Claudia Ferreira CTO	Chief Tech/Sci/R&D Officer	-	13/09/23
Rob van Maanen CTO	Chief Tech/Sci/R&D Officer	54	08/09/21
Pierre Dilda CTO	Chief Tech/Sci/R&D Officer	54	30/11/15
Waly Dioh CTO	Chief Tech/Sci/R&D Officer	55	14/09/06
Jean Mariani BRD	Director/Board Member	74	28/10/19
Edouard Bieth PRN	Corporate Officer/Principal	44	13/09/23
Chiara Baccelli PRN	Corporate Officer/Principal	48	31/12/22

Members of the board	Title	Age	Since
Nadine Coulm BRD	Director/Board Member	61	21/05/15
Claude Allary BRD	Director/Board Member	69	06/07/21
Stanislas Veillet CEO	Chief Executive Officer	58	14/09/06
Jean Mariani BRD	Director/Board Member	74	28/10/19

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,040,482,402	422,265,366 ( 40.58 %)	240,026 ( 0.0231 %)	40.58 %

Name	Equities	%	Valuation
Stanislas Veillet 2.860 %	32,775,471	2.860 %	123 891 €
Gestys SA 1.953 %	22,380,000	1.953 %	84 596 €
Waly Dioh 0.0215 %	246,316	0.0215 %	931 €
Lyxor International Asset Management SAS 0.0207 %	236,829	0.0207 %	895 €
Pierre Dilda 0.0124 %	142,308	0.0124 %	538 €
Ecofi Investissements SA 0.009248 %	105,980	0.009248 %	401 €
Rob van Maanen 0.006630 %	75,983	0.006630 %	287 €
Chiara Baccelli 0.006630 %	75,983	0.006630 %	287 €
Claresco Finance SA 0.002557 %	29,300	0.002557 %	111 €
Nadine Coulm 0.000109 %	1,250	0.000109 %	5 €

Name	Equities	%	Valuation
Morgan Stanley & Co. International Plc 0.0401 %	4,600	0.0401 %	1 615 €
RhumbLine Advisers LP 0.004625 %	530	0.004625 %	186 €

Biophytis SA

Sorbonne Université Bâtiment A 4 ème étage

75005, Paris

+33 1 44 27 23 00

http://www.biophytis.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
BIOPHYTIS S.A.	+16,370.59%	2.57M
VERTEX PHARMACEUTICALS INCORPORATED	-1.65%	103B
REGENERON PHARMACEUTICALS, INC.	+6.75%	101B
ARGENX SE	+5.71%	23.07B
BIONTECH SE	-12.60%	22.23B
GENMAB A/S	-9.70%	18.05B
WUXI APPTEC CO., LTD.	-39.98%	17.18B
BEIGENE, LTD.	-10.17%	16.94B
NEUROCRINE BIOSCIENCES, INC.	+6.12%	14.07B
SAREPTA THERAPEUTICS, INC.	+35.47%	12.35B

Bio Therapeutic Drugs